News

ARGENT gene expression regulation technology is expected to add a valuable tool to Regenx’s NAV platform by providing control of gene expression and the potential for safety and

Through the collaboration with University of Minnesota and James Cloyd, Neurelis has also partnered with experts in clinical research of the nasal delivery of benzodiazepines. The company expects

ANAVEX 2-73 is the first of a new class of oral, disease-modifying drugs being studied to potentially treat AD itself, versus treating its symptoms. The Phase I clinical

The execution of the trial entitles Dynavax to receive a $6m milestone payment from GSK, its partner in a worldwide strategic alliance. As per the terms of the

The study results showed increase in lumbar spine bone mineral density at month 12 for the AMG 785/CDP7851 active arms versus the placebo arm. The study was planned

Elan’s net income was $68.2m, or $0.12 per diluted share, compared to a net loss of $6.8m, or $0.01 per diluted share, for the same period in 2010.

The new EMR suite will ease challenges and will offer safe, secure and user- friendly access for patients, according to the company. Keeping patient’s records in a single

Colesevelam HCI 625mg tablets are generic version of Daiichi Sankyo’s Welchol. Welchol is a bile acid sequestrant. It works to decrease cholesterol by increasing the removal of bile

MicroDose intends to submit the investigational new drug (IND) reactivation with the US Food and Drug Administration and to begin MDT-637Phase I study this year. As per the